San Diego based Stemson Therapeutics will potentially start its human hair regrowth trial in the UK. Stemson is one of the forerunners in the quest for a cure for hair loss. The company adopts a novel approach to hair restoration or hair regrowth using the patient’s own cells to generate new hair follicles. Latest news announcement suggests that Stemson may potentially set up its research and development as well as human trials in the UK. Click Stemson targets UK for its human hair regrowth trial for details.
British “stem cell” treatment claims to reverse hair loss by about 30% to 40%. Doctors in the UK selling the new £2,000 per session “stem cell” procedure claim that it is the world’s first “cure for baldness”. It is reported that the procedure works by using a device called Rigenera Activa which can extract stem cells from fat, skin and hair. Click British stem cell treatment reverses hair loss by up to 40% for details.
In this much anticipated live stream interview, Drs. Marc Avram and Nicole Rogers interviewed Angela M. Christiano, PhD on the topic of 3D printing of scaffolding for human hair follicle neogenesis as a potential cure for hair loss. This live stream interview was part of the Norwood Lecture at the ISHRS 2020 World Congress taking place from October 17-25. Click Dr. Angela Christiano on 3D printing of scaffolding for human hair follicle neogensis to watch a recorded copy of the live stream.
The treatment name is HST-001, or Hair Stimulating Complex (HSC). It is intended to be a relatively safe, minimally invasive physician-administered treatment for hair loss. HSC is formulated to enrich growth factors including KGF, VEGF and follistatin, which are involved in signaling stem cells in the body and have been shown to be important in hair formation and the stimulation of resting hair follicles. Click Histogen announces completion of dosing milestone in its trial for male pattern baldness for details about this announcement.
South Korea Hair Regrowth Peptide PTD-DBM – latest updates for PTD-DBM hair regeneration peptide. News broke out in our forum a few years ago and we now have confirmation that CK Biotechnology is official in human trials with PTD-DBM, a peptide that can regrow hair by functioning as a CXXC5 inhibitor according to the research. Click Korea Hair Regrowth Peptide PTD-DBM to find out availability timeline for this exciting topical treatment for hair loss.
In a study supported by the National Institute of Health, researchers from North Carolina State University have identified a microRNA molecule that could promote hair regeneration and new hair growth bypassing the need for hair stem cells. Trial results show almost 90% hair regrowth in as little as 15 days. Click North Carolina State University microRNA hair regeneration for details.
Exosomes – the latest in cell based hair restoration technologies since Platelet Rich Plasma hair treatment. It has been suggested that Exosomes function as stem cells building blocks that may hold the promise in promoting healthy hair growth. Can Exosomes pave the way for the next generation in minimally invasive cell based hair restotation? Check out Exosomes hair therapy for details.
Hair restoration news – Dr. Tsuji stem cell hair multiplication research will likely be the one that wins the race for a real hair loss cure, according to many in our community. Find out what is so unique about Dr. Tsuji’s hair multiplication research and why many believe that this is the treatment we have all been waiting for. Click Dr Tsuji hair multiplication news for details.
News update on Samumed WNT pathway activator hair loss treatment. Wnt pathway has been extensively studied in recent years and has been implicated in many degenerative diseases and conditions including androgenetic alopecia or pattern baldness in men and women. Samumed, one of the leading biotech companies in Wnt pathway modulation has officially started their phase 2/3 trial for SM04554 for the treatment of androgenetic alopecia. Click Samumed WNT Pathway Activator Hair Loss Treatment for the latest updates and anticipated commercial availability date.
RT1640 Hair Loss Cure? RiverTown Therapeutics’ remarkable 14 weeks before and after patient result sparks extreme interests in our forum community. Could this experimental topical formula be the hair loss cure we are hoping for? The developer of this new product mentioned that one of the key ingredients has been tested in over 600 humans in FDA sanctioned clinical trials already. So how soon can we see this product on the market? Click RiverTown RT1640 Hair Loss Cure for our coverage.
